We are live on ! Find out more
SGC

Slocum, Gordon & Co Portfolio holdings

AUM $151M
1-Year Est. Return 26.83%
This Fund
S&P 500
This Quarter Est. Return
-5.58%
1 Year Est. Return
+26.83%
3 Year Est. Return
+55.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$127M
Cap. Flow
-$203M
Cap. Flow %
-166.6%
Top 10 Hldgs %
55.09%
Holding
141
New
6
Increased
5
Reduced
34
Closed
4

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$1.82M
2
EWA icon
iShares MSCI Australia ETF
EWA
+$1.26M
3
CAT icon
Caterpillar
CAT
+$776K
4
ATO icon
Atmos Energy
ATO
+$128K
5
T icon
AT&T
T
+$120K

Top Sells

Rank Stock Value
1
SO icon
Southern Company
SO
+$79.6M
2
RVTY icon
Revvity
RVTY
+$65.4M
3
STE icon
Steris
STE
+$37.8M
4
NEE icon
NextEra Energy
NEE
+$9.46M
5
ROBT icon
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
+$7.86M

Sector Composition

Rank Sector Weight
1 Healthcare 23.63%
2 Consumer Staples 19.63%
3 Energy 13.16%
4 Utilities 12.86%
5 Communication Services 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
26
Unilever
UL
$137B
$1.29M 1.06%
20,244
-4,705
-19% -$318K
EWA icon
27
iShares MSCI Australia ETF
EWA
$1.38B
$1.17M 0.96%
+48,900
New +$1.26M
WMT icon
28
Walmart Inc
WMT
$885B
$1.07M 0.88%
11,874
-85
-0.7% -$7.38K
UNP icon
29
Union Pacific
UNP
$172B
$1.06M 0.87%
4,637
– –
GEV icon
30
GE Vernova
GEV
$264B
$933K 0.77%
2,837
-50
-2% -$15.6K
CAT icon
31
Caterpillar
CAT
$375B
$907K 0.75%
2,500
+2,000
+400% +$776K
DD icon
32
DuPont de Nemours
DD
$18.6B
$904K 0.74%
9,444
– –
CAG icon
33
Conagra Brands
CAG
$7.04B
$867K 0.71%
31,230
-3,481
-10% -$98.8K
HD icon
34
Home Depot
HD
$328B
$732K 0.6%
1,883
– –
AMZN icon
35
Amazon
AMZN
$2.89T
$548K 0.45%
2,499
– –
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.1T
$543K 0.45%
1,197
– –
DOW icon
37
Dow Inc
DOW
$21.4B
$513K 0.42%
12,778
– –
GIS icon
38
General Mills
GIS
$19.2B
$481K 0.4%
7,540
– –
ABT icon
39
Abbott
ABT
$181B
$481K 0.4%
4,250
– –
PEP icon
40
PepsiCo
PEP
$190B
$354K 0.29%
2,326
– –
NVDA icon
41
NVIDIA
NVDA
$4.75T
$324K 0.27%
2,410
– –
ZTS icon
42
Zoetis
ZTS
$31.7B
$316K 0.26%
1,942
– –
TRV icon
43
Travelers Companies
TRV
$78.5B
$301K 0.25%
1,250
– –
RVTY icon
44
Revvity
RVTY
$12.5B
$297K 0.24%
2,660
-556,579
-100% -$65.4M
AMGN icon
45
Amgen
AMGN
$206B
$293K 0.24%
1,125
– –
TMO icon
46
Thermo Fisher Scientific
TMO
$211B
$286K 0.23%
549
-25
-4% -$13.7K
IVV icon
47
iShares Core S&P 500 ETF
IVV
$869B
$279K 0.23%
474
– –
BMY icon
48
Bristol-Myers Squibb
BMY
$130B
$275K 0.23%
4,854
– –
BRKL
49
DELISTED
Brookline Bancorp
BRKL
$272K 0.22%
23,087
– –
GEHC icon
50
GE HealthCare
GEHC
$30.7B
$233K 0.19%
2,985
-62
-2% -$5.27K
1
2
3 4 5

Similar funds

LM
Lansing Management New York $151M AUM 13.85% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return

Slocum, Gordon & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Slocum, Gordon & Co held 141 positions worth $122M, down 51% from $249M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Slocum, Gordon & Co withdrew a net $203M in Q4 2024, closing 4 positions and reducing 34 holdings. Its most notable exit was Steris, an estimated $37.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Energy.

Against the trend, Slocum, Gordon & Co opened a new position in iShares MSCI Australia ETF worth $1.17M.

  • Slocum, Gordon & Co's largest Q4 2024 buy was iShares MSCI Australia ETF: 48,900 shares worth $1.17M.
  • Slocum, Gordon & Co added most to Colgate-Palmolive in Q4 2024, an estimated $1.82M increase.
  • Slocum, Gordon & Co's biggest Q4 2024 reduction was Southern Company, cutting an estimated $79.6M.
  • Slocum, Gordon & Co fully exited Steris in Q4 2024, selling an estimated $37.8M.
  • Slocum, Gordon & Co's ten largest holdings make up 55% of its $122M portfolio in Q4 2024.
  • Slocum, Gordon & Co opened 6 new positions and closed 4 in Q4 2024.
  • Slocum, Gordon & Co's portfolio value fell 51% quarter-over-quarter to $122M.

Based on Slocum, Gordon & Co's 13F filing for Q4 2024, filed 28 Jan 2025.